United Therapeutics Corporation (UTHR)
Net profit margin
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 1,195,100 | 984,800 | 727,300 | 475,800 | 514,800 |
Revenue | US$ in thousands | 2,877,400 | 2,327,500 | 1,936,300 | 1,685,500 | 1,483,300 |
Net profit margin | 41.53% | 42.31% | 37.56% | 28.23% | 34.71% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $1,195,100K ÷ $2,877,400K
= 41.53%
The net profit margin measures the percentage of revenue that remains as profit after all expenses have been deducted. United Therapeutics Corporation's net profit margin has shown fluctuations over the years, ranging from 28.23% in December 31, 2021, to a peak of 42.31% in December 31, 2023. This indicates that the company has been effective in managing its costs and generating profits from its operations. The consistent profitability reflected in the margins suggests a strong financial performance and efficiency in operations during this period. The increasing trend from 2021 to 2024 demonstrates an improvement in profitability, which could be a positive sign for investors and stakeholders.
Peer comparison
Dec 31, 2024